Dual therapy for pulmonary hypertension before balloon pulmonary angioplasty is linked to fewer thoracic complications than monotherapy in patients with chronic thromboembolic pulmonary hypertension.

Pulmonary arterial hypertension is a devastating disorder characterized by precapillary pulmonary hypertension not caused by respiratory disease, obstruction of the pulmonary arteries, or certain less ...

This review focuses on recent studies relevant to the management of hypertension in patients with COPD. Contemporary evidence concerning the effects of antihypertensive-drug classes on COPD ...

Effect of oxymatrine on the side population and expression of β-catenin in MCF-7 breast cancer cells. Background: This study evaluates patients for increased pulmonary arterial pressures when treated ...

Adding the experimental inhaled therapy LAM-001 to ongoing treatment for PH-ILD may help reduce symptoms in a clinically ...

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries in your lungs. It happens when these arteries become narrow or blocked, making it harder for blood to flow ...

Common tests to diagnose pulmonary hypertension include chest X-rays to check for enlarged ventricles or lung issues, blood tests to assess oxygen levels and organ function, and a 6-minute walk test ...

Pulmonary hypertension means high blood pressure in the arteries between the heart and lungs. The World Health Organization (WHO) divides pulmonary hypertension into five categories based on its cause ...

Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.